Sanjay Chanda, SVP, Drug Development at Anacor Pharmaceuticals, Inc. (ANAC), sold 10,000 shares at $24.25 ($243K) on 2014-09-10, disclosed to the SEC on 2014-09-12.
Scheduled sale ($242k) by SVP, Drug Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.25 | 4,953 | $120K | 49.5% |
| 2 | $24.25 | 5,047 | $122K | 50.5% |
| Total | $24.25 avg | 10,000 | $243K | 100% |
| Filing → |
| ANAC | SELL | 2015-03-04 | $225K | — | Filing → |
| ANAC | SELL | 2014-12-01 | $175K | — | Filing → |